News Links
Celiac News from October 11, 2017
Common antibiotics not associated with increased risk of Type 1 diabetes or celiac disease in children. See also Early antibiotics use not associated with type 1 diabetes or celiac disease, study suggests.
Read MoreDaily Care News from October 11, 2017
Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from pediatric to adult services (TrACeD): a randomized, open-label, controlled trial. Free full text available in HTML and PDF formats. Type 1 Diabetes and Long-Term Continuous Subcutaneous Insulin Infusion Therapy: A 10-Year Experience from Macedonia. Determinants of preeclampsia in women with type 1 diabetes. Differential effects of age and sex on insulin sensitivity and body composition in adolescent offspring of women with type 1 diabetes: results from the EPICOM study. Association of Type 1 Diabetes, Social Support, Illness and Treatment Perception with Health Related Quality of Life. Insulin Injection […]
Read MoreResearch News From October 10, 2017
Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Free full text available in PDF format. See also The risk of type 1 diabetes not increased by swine flu vaccine Pandemrix. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine. The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age. Association of glycemic control with reduced risk of large vessel disease after more than […]
Read MorePress Releases from October 4, 2017
Novo Nordisk Receives FDA Approval for Fiasp®, a New Fast-Acting Mealtime Insulin. No More Routine Finger Sticks for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.. See also FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration and How Abbott’s Big Win Crushed DexCom Shares.
Read MorePopular Press from October 4, 2017
Teal Pumpkin Project: Alternative Halloween treats for kids with allergies, diabetes or other needs. Model predicts performance of glucose-responsive insulin. Boy Living With Type 1 Diabetes Excels on Baseball Diamond. Diabetes Ambassador Emily Wilson plans big adventure with Jerry the Bear. Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problem.
Read MoreCeliac News from October 4, 2017
Efficacy of a point-of-care test based on deamidated gliadin peptides for the detection of celiac disease in pediatric patients. Free full text available in PDF format. Increased prevalence of fracture and hypoglycaemia in young adults with concomitant type 1 diabetes mellitus and coeliac disease. Low-gluten, non-transgenic wheat engineered with CRISPR/Cas9. See also Scientists Gene-Edited Gluten to Make Wheat for People With Celiac Disease and Could a GMO Wheat Bring Bread to Celiac Sufferers? We have a list of Gluten Free Halloween Candy for families living with celiac.
Read MoreDaily Care News from October 4, 2017
Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries. The Financial Impact of Inaccurate Blood Glucose Monitoring Systems. Free full text available in HTML and PDF formats. Does funded research reflect the priorities of people living with type 1 diabetes? A secondary analysis of research questions. Free full text available in HTML and PDF formats. Self-stigma of Patients with Type 1 Diabetes and Their Coping Strategies. The impact of ethnicity, educational and economic status on the prescription of insulin therapeutic regimens and on glycemic control in patients with type 1 diabetes. A nationwide study in Brazil. Trends in the […]
Read MoreResearch News From October 4, 2017
The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes. In Silico Modeling of Minimal Effective Insulin Doses Using the UVA/PADOVA Type 1 Diabetes Simulator.
Read More